UPDATE 2-Chiron posts profit, writes off flu shot inventory
45398
Chiron Corp. (CHIR.O: Quote, Profile, Research) , barred from shipping its flu vaccine after it was found to be contaminated, on Wednesday posted a quarterly
551540
YESTERDAY Close $45.95 Change -$0.51 52-WEEK High $51.50 Low $33.73 The medical research and services company Charles River Laboratories International Inc. of Wilmington said fourth-quarter profit dropped 30 percent due in large part to a year-ago provision for income taxes.
401539
Chiron Corp., which makes nearly half the country&#39;s flu shots, announced Thursday some batches of the Fluvirin flu vaccine made in its England factory were found to be contaminated.
164100
WASHINGTON - The Food and Drug Administration said Friday that flu vaccine manufactured in Britain by Chiron Corp. is not usable. The announcement ended hopes that at least some batches of the vaccine were salvageable.
104396
Federal regulators reportedly found manufacturing problems at Chiron&#39;s flu-vaccine plant in England last year similar to those that led British authorities to shut down the facility last week.
610138
None of Chiron Corp.'s CHIR.O flu  vaccine made at a British plant is safe, which means the U.S.  flu vaccine supply will be half of what was expected, U.S.  health officials said on Friday.
143291
US health officials have confirmed that the entire stock of flu vaccine from a British producer is unusable. The US had hoped to salvage some of the doses made by Chiron, which account for nearly half of its annual supply.
326621
Chiron Corp. , which had to scrap its flu vaccine this season due to contamination, said on Friday it has received a warning from US regulators in connection with its shuttered vaccine manufacturing plant in England.
439792
Federal regulators said an inspection of Chiron Corp.'s (CHIR) flu-vaccine plant in England last year turned up manufacturing problems similar to those that led British authorities to shut down the facility ...
86826
LONDON: Britain has suspended the manufacturing licence of Chiron Corp, a major supplier of flu vaccine to the UK and the US, for three months.
379203
Chiron Corp. is working with British regulators who suspended its license to sell a flu vaccine and is hoping authorities will lift the suspension in time for the 2005-2006 flu season, the company said Friday.
222125
Shares of Chiron Corp., the world&#39;s second-biggest seller of influenza vaccines, fell as much as 9.5 percent after saying it would delay shipments of its Fluvirin flu shots until October because of a possible product flaw.
273496
Chiron Corp. is making progress in  fixing the problems at its British vaccine plant that cost the  United States half its expected flu shot supply this year, a  Food and Drug Administration official said on Thursday.
584086
Biotech and pharmaceutical stocks showed no signs of slowing down Friday afternoon amid news that vaccine maker Chiron Corp. was going deliver its flu vaccine a month late this year because some lots had been contaminated.
738503
YESTERDAY Close $54.64 Change +$1.53 52-WEEK High $55.14 Low $42.29 Merck &amp; Co., the third-largest US drug maker, reported a 63 percent increase in earnings and raised its forecast for the year after a vaccine for cervical cancer and a new pill for diabetes drove sales higher.
617585
Chiron Corp. is working with British  regulators who suspended its license to sell a flu vaccine and  is hoping authorities will lift the suspension in time for the  2005/2006 flu season, the company said on Friday.
734292
The cardiovascular device maker said its second-quarter profit, excluding charges, was $271 million, or 18 cents per share, compared with $412 million, or 31 cents per share, a year ago.